The Leadership Team
With 15 years of experience in the design and development of sustainable hospital hygiene solutions, Germitec is a market leader in automated UV-C solutions for ultrasound probe disinfection, replacing chemistry with photons to radically simplify the lives of healthcare professionals in terms of safety, time and liability.
Germitec has a proven track record of product development and sales growth and strong prospects for expansion.
A new management team has been appointed in early 2022 with the aim to support and accelerate Germitec’s development and drive its long-term strategy.
CEO and Board Member
Vincent has 25 years of successful experience in the medical device industry, both in large international companies (Medtronic, Stryker, Bard) and in the development of innovative startups (Vexim, Kumovis, Amber Implants). Vincent brings solid expertise in International and European sales, marketing, human resources, and experience in financial management (IPO, secondary offerings, mergers and acquisitions). Among his successes, Vincent was instrumental in Stryker’s acquisition of Vexim (specialist in treatment of vertebral compression fractures with its SpineJack® device) at the end of 2017 for €183M. He recently supported the acquisition of Kumovis by 3D Systems (price undisclosed).
José Da Gloria
Deputy CEO and Chief Financial Officer
José has more than 20 years of successful experience in finance acquired both in large corporations (Dell, ev3 acquired by Covidien) and in medical device and biotech start-ups, with a successful track record in building and leading large financial transactions. José also strongly contributed to the successful acquisition of Vexim by Stryker. At GERMITEC, José will oversee the financial performance as well as all administrative, HR and strategic projects developments.
Chief Operations Officer